ArticleFrontiers in oncology2024
Comprehensive liquid biopsy analysis for monitoring NSCLC patients under second-line osimertinib treatment.
Aliki Ntzifa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it